A randomized, double-blind, phase III, comparative study of Cidecin (daptomycin) to Rocephin (ceftriaxone) in the treatment of moderate to severe community-acquired acute bacterial pneumonia due to S. [Streptococcus] pneumoniae

Trial Profile

A randomized, double-blind, phase III, comparative study of Cidecin (daptomycin) to Rocephin (ceftriaxone) in the treatment of moderate to severe community-acquired acute bacterial pneumonia due to S. [Streptococcus] pneumoniae

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Oct 2007

At a glance

  • Drugs Ceftriaxone; Daptomycin
  • Indications Community-acquired pneumonia; Pneumococcal infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Cubist Pharmaceuticals
  • Most Recent Events

    • 09 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top